OPX-212

N/A

Report date: 2024/11/18 15:23:28

Base Information

Drug NameOPX-212
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionAquaporins 4 modulators
TargetsAquaporins 4
Therapy Area/IndicationsNeuromyelitis Optica
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOpexa Therapeutics, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcer Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeuromyelitis Optica

Other Information

ATC CodeN/A
Related LinksN/A